Form 4: Agilon Health CEO Steven Sell Acquires 20,000 Shares

Agilon Health's CEO, Steven Sell, recently purchased 20,000 shares of the company's common stock at an average price of $3.3594 per share.

Summary

• On September 12, 2024, Steven Sell, the CEO and President of Agilon Health, acquired 20,000 shares of common stock.
• The shares were purchased at a weighted average price of $3.3594, with individual transactions ranging from $3.31 to $3.37.
• Following the transaction, Sell directly owns 328,447 shares, which includes restricted stock units.
• Sell also indirectly owns 67,590 shares through the Steven J. Sell and Margaret D. Williams Revocable Inter Vivos Trust Agreement.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's stock purchase is generally a good sign, but it's a single transaction and doesn't provide a comprehensive view of the company's health.

Positives

• The CEO's purchase of company stock may signal confidence in Agilon Health's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.

Stakeholder Impact

• The CEO's stock purchase could positively influence shareholder sentiment.

Key Dates